NOM sells Polyganics to CMI

Polyganics was founded in 1999 as a spin-out of the University of Groningen and has since developed and brought to the market several innovative products based on its own polymer platform technology. The unique bioresorbable products are aimed at the recovery of tissue after surgery.

Ready for the next step

"We are very proud of Polyganics and what the team has achieved since its start in 1999," say Annemieke Wouterse and Ytsen van der Meer, Investment Managers of NOM. "The company is ready for the next phase. We expect Polyganics with the broad knowledge base, the already developed products and the state-of-the-art production facility on the Zernike Campus, under the wings of CMI, has a bright future ahead of it. Polyganics' success is based on its experienced, knowledgeable and dedicated team of employees and strong collaboration with key opinion leaders in the various markets."

Also positive for the region

Rudy Mareel, CEO of Polyganics, said: "This transaction is an excellent next step in the further development of Polyganics. As a result, the company obtains additional resources to further expand both its research and production capacity and to accelerate the bringing of groundbreaking products to the market. I am incredibly proud of the team we have under the banner of Polyganics and with which we have been able to develop the groundbreaking technology of biocompatible and bioresorbable polymers. Not only the employees of Polyganics will reap the benefits of the merger of the two companies, but also the Groningen region and in particular the Zernike Campus, which is richer in an even stronger innovative company through this transaction."

Source article: NOM